BioSpace News Archive

To enhance the environmental-friendliness, governments are banning the application of phthalate IV bags as much as possible.

Virtual technology is making strides across almost all sectors, and the healthcare sector is not left behind.

According to the report, the global ethylene-vinyl acetate infusion bags market was valued at ~US$ 128 Mn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.

Cell harvesting is a procedure in which stem cells are harvested to restore, replace, or repair the weakened organ with good working ones.

DNA synthesizers are systems used to build DNA molecules containing a particular sequence of nucleotides. Synthesizers can create specific DNA molecules for use in the treatment of various diseases by replacing a faulty or damaged section of DNA with a repaired section.

Hemogenyx Pharmaceuticals plc announces that it has extended a development agreement with a leading global pharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products.

Aridis Pharmaceuticals, Inc. announced the Company will present at the ROTH Capital Partners 2020 MedTech Innovation Forum on Wednesday, October 28, 2020.

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services reported it has expanded operations into Arizona by establishing its third outpatient radiology joint venture with CommonSpirit Health and completing the acquisition of AZ Tech MRI & Radiology, an eight location multimodality radiology practice.

Centene Corporation announced its financial results for the third quarter ended September 30, 2020, reporting diluted earnings per share of $0.97 and Adjusted diluted EPS of $1.26, including the risk corridor, charitable contribution commitment to the Company’s foundation and tax benefit highlighted below.

Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, announced the appointment of Miriam Bujny, Ph.D., as Chief Development Officer.